Beta-talasemija intermedija i minor
Opstetricija
Variable efficacy of recombinant human erythropoietin in anemic pregnant women with different forms of heterozygous hemoglobinopathy. (otvara se novi prozor)
Izvor: Acta Haematol 2006;116(4):259-65.
Indeks: PubMed 17119327
DOI: 10.1159/000095877
https://www.ncbi.nlm.nih.gov/pubmed/17119327 (otvara se novi prozor)
Erythropoietin use in a pregnant Jehovah's Witness with anemia and beta-thalassemia: a case report. (otvara se novi prozor)
Izvor: J Reprod Med 2005;50(2):135-7.
Indeks: PubMed 15755051
https://www.ncbi.nlm.nih.gov/pubmed/15755051 (otvara se novi prozor)
Preliminary results with administration of recombinant human erythropoietin in sickle cell/beta-thalassemia patients during pregnancy. (otvara se novi prozor)
Izvor: Eur J Haematol 1996;56(5):326-8.
Indeks: PubMed 8641410
https://www.ncbi.nlm.nih.gov/pubmed/8641410 (otvara se novi prozor)
Induction of fetal hemoglobin synthesis with recombinant human erythropoietin in anemic patients with heterozygous beta-thalassemia during pregnancy. (otvara se novi prozor)
Izvor: J Matern Fetal Med 1999;8(1):1-7.
Indeks: PubMed 10052837
DOI: 10.1002/(SICI)1520-6661(199901/02)8:1<1::AID-MFM1>3.0.CO;2-O
https://www.ncbi.nlm.nih.gov/pubmed/10052837 (otvara se novi prozor)
Effective treatment of beta-thalassemia intermedia during pregnancy with rHuEpo. A case report. (otvara se novi prozor)
Izvor: Minerva Ginecol 2000;52(1-2):29-31.
Indeks: PubMed 10851861
https://www.ncbi.nlm.nih.gov/pubmed/10851861 (otvara se novi prozor)